4
Changes in Ownership
MAXCYTE, INC. Filed Acc 0001209191-21-064875
President and CEO sold 300,000 shares at an average $12.31 ($3,692,932)
- President and CEO acquired 200,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Doerfler Douglas President and CEO | 2021-11-12 | Option exercise | +1,847 | $0.04 | $74 | 435,044 | D: show line 1 in the form |
| Doerfler Douglas President and CEO | 2021-11-12 | Sale | −101,847 | $12.66 | $1,289,383 | 333,197 | D: show line 2 in the form |
| Doerfler Douglas President and CEO | 2021-11-15 | Option exercise | +123,263 | $0.04 | $4,931 | 456,460 | D: show line 3 in the form |
| Doerfler Douglas President and CEO | 2021-11-15 | Sale | −123,263 | $12.16 | $1,498,878 | 333,197 | D: show line 4 in the form |
| Doerfler Douglas President and CEO | 2021-11-16 | Option exercise | +74,890 | $0.04 | $2,996 | 408,087 | D: show line 5 in the form |
| Doerfler Douglas President and CEO | 2021-11-16 | Sale | −74,890 | $12.08 | $904,671 | 333,197 | D: show line 6 in the form |
| Open-market sales · 300,000 sh · avg $12.31 · $3,692,932 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Doerfler Douglas President and CEO | 2021-11-12 | Option exercise · Employee Stock Option (right to buy) | −1,847 | 643,233 | D: show line 7 in the form | ||
| Doerfler Douglas President and CEO | 2021-11-15 | Option exercise · Employee Stock Option (right to buy) | −123,263 | 519,970 | D: show line 8 in the form | ||
| Doerfler Douglas President and CEO | 2021-11-16 | Option exercise · Employee Stock Option (right to buy) | −74,890 | 445,080 | D: show line 9 in the form |
Loading xslF345X03/doc4.xml…